ArticleFrontiers in medicine2022

Volatile organic compound profiling as a potential biomarker in irritable bowel syndrome: A feasibility study.

Kathleen Van Malderen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.